Structural transformations during swelling of polycomplex matrices based on countercharged (meth)acrylate copolymers (Eudragit® EPO/Eudragit® L 100-55)

Journal of Pharmaceutical Sciences

Volumn 100, Issue 3, 2011, Pages 874-885

  Moustafine, Rouslan I ^a   Bobyleva, Valerija L ^a   Bukhovets, Aleksandra V ^a   Garipova, Venera R ^a   Kabanova, Tatyana V ^a   Kemenova, Vera A ^b   Van Den Mooter, Guy ^c  

^a KAZAN STATE MEDICAL UNIVERSITY   (Russian Federation)

^b All Russia Science Research Institute of Medicinal and Aromatic Plants   (Russian Federation)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Controlled release; Diclofenac sodium; Eudragit EPO; Eudragit L 100 55; FTIR; glass transition; Interpolyelectrolyte complexes; Oral drug delivery; PH dependent swelling behavior; Polymeric drug carrier

Indexed keywords

COPOLYMER; DICLOFENAC; EUDRAGIT; METHACRYLIC ACID;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; GASTROINTESTINAL TRACT; INFRARED SPECTROSCOPY; PH; TEMPERATURE;

EID: 79251564913     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22320     Document Type: Article

References (51)

1. Dittgen M, Durrani M, Lehmann K. 1997. Acrylic polymers. A review of pharmaceutical applications. STP Pharma Sci 7:403-437.
2. Skalsky B, Petereit H-U. 2008. Chemistry and application properties of polymethacrylate systems. In Aqueous polymeric coatings for pharmaceutical dosage forms; McGinity JW, Felton LA, Eds. 3rd ed. New York: Informa Healthcare, pp 237-279.
3. Siepmann F, Siepmann J, Walther M, MacRae RJ, Bodmeier R. 2008. Polymer blends for controlled release coatings. J Control Release 125:1-15.
4. Gallardo D, Skalsky B, Kleinebudde P. 2008. Controlled release solid dosage forms using combinations of (meth)acrylate copolymers. Pharm Dev Technol 13(5):413-423.
5. Cameron CG, McGinity JW. 1987. Controlled-release theophylline tablet formulations containing acrylic resins, part 2: Combination resin formulations. Drug Dev Ind Pharm 13(8):1409-1427.
6. Fernandez-Arevalo M, Holgado-Villafuerte MA, Gines-Dorado JM, Rabasco-Alvarez AM. 1993. Effects of different fillers and wetting liquids on the dissolution behavior of cartelol hydrochloride controlled release inert matrix tablets. Int J Pharm 95:117-125.
7. Skalsky B, Nollenberger K, Gryczke A. 2009. Melt extruded modified release micropellets using polymethacrylates. In Transactions of 36th Annual Meeting & Exposition of the CRS, Copenhagen, July 18-22, Denmark.
8. Ceballos A, Cirri M, Maestrelli F, Corti G, Mura P. 2005. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets. Farmaco 60(11-12):913-918.
9. Ammar HO, Khalil RM. 1997. Preparation and evaluation of sustained-release solid dispersions of drugs with Eudragit polymers. Drug Dev Ind Pharm 23(11):1043-1054.
10. Kislalioglu MS, Khan MA, Blount C, Goettsch RW, Bolton S. 1991. Physical characterization and dissolution properties of ibuprofen: Eudragit coprecipitaties. J Pharm Sci 80(8):799-804.
11. Lorenzo-Lamoza ML, Cuña M, Vila-Jato JL, Torres D, Alonso MJ. 1997. Development of a microencapsulated form of cefuroxime axetil using pH-sensitive acrylic polymers. J Microencapsul 14(5):607-616.
12. Kiliçarslan M, Baykara T. 2004. Effects of the permeability characteristics of different polymethacrylates on the pharmaceutical characteristics of verapamil hydrochloride-loaded microspheres. J Microencapsul 21(2):175-189.
13. Akhgari A, Sadeghi F, Garekani HA. 2006. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets. Int J Pharm 320:137-142.
14. Wu CB, McGinity JW. 2003. Influence of an enteric polymer on drug release rates of theophylline from pellets coated with Eudragit® RS 30D. Pharm Dev Technol 8(1):103-110.
15. Katsuma M, Watanabe S, Takemura S, Sako K, Sawada T, Masuda Y, Nakamura K, Fukui M, Connor AL, Wilding IR. 2004. Scintigraphic evaluation of a novel colon-targeted delivery system (CODES™) in healthy volunteers. J Pharm Sci 93(5):1287-1299.
16. Vasilevska K, Djurić Z, Jovanović, Simov A. 1992. Preparation and dissolution characteristics of controlled release diltiazem pellets. Drug Dev Ind Pharm 18(15):1649-1661.
17. Sauer D, Watts AB, Coots LB, Zheng WC, McGinity JW. 2009. Influence of polymeric subcoats on the drug release properties of tablets powder-coated with pre-plasticized Eudragit® L 100-55. Int J Pharm 367:20-28.
18. Sauer D, McGinity JW. 2009. Properties of theophylline tablets dry powder coated with Eudragit® EPO and Eudragit® L 100-55. Pharm Dev Technol 16(6):632-641.
19. Gupta VK, Beckert TE, Deusch NJ, Hariharan M, Price JC. 2002. Investigation of potential ionic interactions between anionic and cationic polymethacrylates of multiple coatings of novel colonic delivery system. Drug Dev Ind Pharm 28(2):207-215.
20. Obeidat WM, Abu Znait AH, Sallam AA. 2008. Novel combination of anionic and cationic polymethacrylate polymers for sustained release tablet preparation. Drug Dev Ind Pharm 34(6):650-660.
21. Obeidat WM, Abu Znait AH, Sallam AA. 2010. Sustained release tablets containing soluble polymethacrylates: Comparison with tableted polymethacrylate IPEC polymers. AAPS Pharm Sci Tech 11(1):54-63.
22. Zezin AB, Rogacheva VB. 1973. Polyelectrolyte complexes. In Achievements of the Physics and Chemistry of Polymers; [in Russia], Moscow: Khimiya, pp 3-30.
23. Tsuchida E. 1994. Formation of polyelectrolyte complexes and their structures. J Macromol Sci Pure Appl Chem A 31:1-15.
24. Thünemann AF, Müller M, Dautzenberg H, Joanny J-F, Löwen H. 2004. Polyelectrolyte complexes. Adv Polym Sci 166:113-171.
25. Kemenova VA, Moustafine RI, Alekseyev KV, Scorodinskaya AM, Zezin AB, Tenchova AI, Kabanov VA. 1991. Applying interpolymer complexes in pharmacy. Pharmacya 60(1):67-72.
26. Hartig MS, Greene RR, Dikov MM, Prokop A, Davidson JM. 2007. Multifunctional nanoparticulate polyelectrolyte complexes. Pharm Res 24(12):2353-2369.
27. Khutoryanskiy VV. 2007. Hydrogen-bounded interpolymer complexes as materials for pharmaceutical applications. Int J Pharm 334:15-26.
28. Khutoryanskiy VV. 2009. Pharmaceutical applications of interpolymer complexes. In Hydrogen-bonded interpolymer complexes. Formation, structure and applications; Khutoryanskiy VV, Staikos G, Eds. Singapore: World Scientific Publishing Co. Pte. Ltd., pp 235-258.
29. Lankalapalli S, Kolapalli VRM. 2009. Polyelectrolyte complexes: A review of their applicability in drug delivery technology. Ind J Pharm Sci 71:481-487.
30. Mustafin (Moustafine) RI, Kabanova TV. 2004. Synthesis and characterization of an interpolyelectrolyte complex based on Eudragit E100 and L100 copolymers. Pharm Chem J 38(11):625-627.
31. Mustafin (Moustafine) RI, Kabanova TV. 2005. Diffusion transport properties of polymeric complex matrix systems based on Eudragit E100 and L100 copolymers. Pharm Chem J 39(2):89-93.
32. Moustafine RI, Kabanova TV, Kemenova VA, Van Den Mooter G. 2005. Characteristics of interpolyelectrolyte complexes of Eudragit E100 with Eudragit L100. J Control Release 103:191-198.
33. Moustafine RI, Zaharov IM, Kemenova VA. 2006. Physicochemical characterization and drug release properties of Eudragit® EPO/ Eudragit® L100-55 interpolyelectrolyte complexes. Eur J Pharm Biopharm 63(1):26-36.
34. Moustafine RI, Bobyleva OV. 2006. Design of new polymer carriers based of Eudragit® EPO/Eudragit® L100-55 interpolyelectrolyte complexes using swelliability measurements. J Control Release 116(2):e35-e36.
35. Cilurzo F, Minghetti P, Casiraghi A, Montanari L. 2000. Evaluation of compatibility of methacrylic copolymers by capillary viscosimetry. J Appl Polym Sci 76:1662-1668.
36. Menjoge AR, Kulkarni MG. 2007. Mechanistic investigations of phase behavior in Eudragit®E blends. Int J Pharm 343:106-121.
37. Gallardo D, Assmus M, Kleinebudde P, Skalsky B. 2007. Formation of precipitates prepared by mixing countercharged (meth)acrylate copolymers. In AAPS Annual Meeting, San Diego, November 11-15, CA.
38. Gallardo D, Assmus M, Kleinebudde P, Skalsky B. 2007. Analytical characterization of (meth)acrylate copolymer complexes. In AAPS Annual Meeting, San Diego, November 11-15, CA.
39. Gallardo D, Assmus M, Kleinebudde P, Skalsky B. 2008. Stoichiometry of complexes formed between Eudragit® E PO and Eudragit® L100-55. In Proceedings of the 6th World Meeting (APV/APGI) on Pharmaceutics, Biopharmaceutics, and Pharmaceutical Technology, Barcelona, April 7-10, Spain.
40. Moustafine RI, Margulis EB, Sibgatullina LF, Kemenova VA, Van Den Mooter G. 2008. Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit® L100 and Eudragit® L100-55 for oral controlled drug delivery. Eur J Pharm Biopharm 70(1):215-225.
41. Moustafine RI, Salachova AR, Frolova ES, Kemenova VA, Van Den Mooter G. 2009. Interpolyelectrolyte complexes of Eudragit® EPO with sodium alginate as potential carriers for colonic drug delivery: Monitoring of structural transformation and composition changes during swellability and release evaluating. Drug Dev Ind Pharm 35(12):1439-1451.
42. Lorenzo-Lamoza ML, Remuňán-Lopez C, Vila-Jato JL, Alonso MJ. 1998. Design of microencapsulated chitosan microspheres for colonic drug delivery. J Control Release 52:109-118.
43. Ali Said, A.E-H. 2005. Radiation synthesis of interpolymer polyelectrolyte complex and its application as a carrier for colon-specific drug delivery system. Biomaterials 26(15):2733-2739.
44. Zhang Y, Hu L, Min Y, Zhai M, Wang J, Ha H. 2006. Radiation synthesis of poly[(dimethylaminoethyl methacrylate)-co-(diallyl dimethyl ammonium chloride)] hydrogels and its application as a carrier for notoginsenoside delivery. Eur Polym J 42(11):2959-2967.
45. Qi S, Gryczke A, Belton P, Craig DQM. 2008. Characterisation of solid dispersions of paracetamol and EUDRAGIT® E prepared by hot-melt extrusion using thermal, microthermal and spectroscopic analysis. Int J Pharm 354:158-167.
46. Albers J, Alles R, Matthée K, Knop K, Nahrup JS, Kleinebudde P. 2009. Mechanism of drug release from polymethacrylate-based extrudates and milled strands prepared by hot-melt extrusion. Eur J Pharm Biopharm 71(2):387-394.
47. Kwei TK, Pearce EM, Pennacchia JR. 1987. Correlation between the glass transition temperatures of polymer mixtures and intermolecular force parameters. Macromolecules 20(4):1174-1176.
48. Gordon S, Taylor JS. 1952. Ideal copolymers and the second-order transitions of synthetic rubbers, part I: Non-crystalline copolymers. J Appl Chem 2:493-500.
49. Simha R, Boyer RF. 1962. On a general relation involving the glass temperatures and coefficient of expansion of polymers. J Chem Phys 37:1003-1017.
50. Quinteros DA, Ramirez Rigo V, Jimenez Kairuz AF, Olivera ME, Manzo RH, Allemandi DA. 2008. Interaction between a cationic polymethacrylate (Eudragit E100) and anionic drugs. Eur J Pharm Sci 33:72-79.
51. Sipos P, Szucs M, Szabó A, Eros I, Szabó-Révész P. 2008. An assessment of the interaction between diclofenac sodium and ammonio methacrylate copolymer using thermal analysis and Raman spectroscopy. J Pharm Biomed Anal 46:288-294.